Ptc Therapeutics (PTCT) Net Income Growth (3y) (2015 - 2026)
Ptc Therapeutics (PTCT) Net Income Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | 9.16% |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.89 Bn | 468.10 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 122.12 Bn | 114.87 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | -3.84% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | 79.26% |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 47.10% |
| 10 | Ptc Therapeutics | 6.31 Bn | 4.41 Bn | 244.52 Mn | 72.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.76% |
| Dec 31, 2025 | 15.42% |
| Sep 30, 2025 | 28.97% |
| Jun 30, 2025 | 24.73% |
| Mar 31, 2025 | 106.75% |
| Dec 31, 2024 | 78.02% |
| Sep 30, 2024 | 7.24% |
| Jun 30, 2024 | 5.73% |
| Mar 31, 2024 | 10.71% |
| Dec 31, 2023 | -39.27% |
| Sep 30, 2023 | -24.03% |
| Jun 30, 2023 | -3.11% |
| Mar 31, 2023 | -7.24% |
| Dec 31, 2022 | -48.35% |
| Sep 30, 2022 | -22.14% |
| Jun 30, 2022 | -53.82% |
| Mar 31, 2022 | -20.68% |
| Dec 31, 2021 | -42.16% |
| Sep 30, 2021 | -37.89% |
| Jun 30, 2021 | -131.67% |